Learn More
Medchemexpress LLC N-[3-oxo-3-[[(1R)-1,2,3,4-tetrahydro-1-naphthalenyl]amino]propyl]-4-(trifluoromethoxy)-benzamide | 2029049-79-2 | MFCD30489750 | 99.7% | 406.40 | C21H21F3N2O3 | 5 MG

Supplier: Medchemexpress LLC HY1006885MG
ML390 is a small-molecule inhibitor of dihydroorotate dehydrogenase (DHODH) that induces myeloid differentiation in murine and human acute myeloid leukemia (AML) models. It is supplied as a solid research-grade compound for biochemical and cellular studies.
- Potent DHODH inhibitor that induces myeloid differentiation in AML models.
- High purity (99.72%) suitable for biochemical and cellular assays.
- Molecular weight 406.40 and formula C21H21F3N2O3 for accurate dosing and calculations.
- White to off-white solid appearance, easy to handle and weigh.
- Stable as a powder at -20°C for up to 3 years and at 4°C for up to 2 years.
- Available in small research pack sizes including 5 mg for screening and pilot studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.